Adults with high cholesterol taking statins may have a significantly higher risk of developing glaucoma than those not taking the cholesterol-lowering drugs, an observational study of a large research ...

Use of the dual GIP/GLP-1 drug tirzepatide (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma compared with GLP-1 drugs among patients with type 2 diabetes, a large ...

Glaucoma medications were associated with a reduced likelihood of death in U.S. adults with glaucoma, according to a study published in the February issue of the Archives of Ophthalmology. Researchers ...

The loss of retinal ganglion cells (RGCs) is a prevalent characteristic of glaucoma and often the reason behind disease progression. Now, a team of researchers has utilized AI to identify a RIPK3 ...

Use of GLP-1 receptor agonists for obesity was tied to a reduced risk of glaucoma versus other weight-loss drugs. The findings were in line with those of a previous study that included patients ...

A retrospective study suggested that use of the dual GIP/GLP-1 drug tirzepatide was associated with a significantly reduced risk of glaucoma compared with GLP-1 drugs among patients with type 2 ...